Jazz Pharmaceuticals plc Earnings Per Share Diluted

• Jazz Pharmaceuticals plc showed a decrease of -167.5% in Earnings Per Share Diluted from 2024 to 2025.
• This data is from Jazz Pharmaceuticals plc's annual report (Form 10-K), filed with the SEC on February 24, 2026.
• XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Quarterly values from 10-Q filings: Q1 2014: $1.58 (loss) per share | Q2 2014: $0.70 per share | Q3 2014: $0.41 per share | Q4 2014: $1.30 per share | Q1 2015: $1.12 per share | Q2 2015: $1.40 per share | Q3 2015: $1.39 per share | Q4 2015: $1.32 per share | Q1 2016: $1.21 per share | Q2 2016: $1.85 per share | Q3 2016: $1.45 per share | Q4 2016: $1.91 per share | Q1 2017: $1.41 per share | Q2 2017: $1.72 per share | Q3 2017: $1.03 per share | Q4 2017: $3.79 per share | Q1 2018: $0.75 per share | Q2 2018: $1.50 per share | Q3 2018: $2.41 per share | Q4 2018: $2.64 per share | Q1 2019: $1.47 per share | Q2 2019: $4.56 per share | Q3 2019: $1.78 per share | Q4 2019: $1.29 per share | Q1 2020: $2.82 (loss) per share | Q2 2020: $2.06 per share | Q3 2020: $2.64 per share | Q4 2020: $2.33 per share | Q1 2021: $2.09 per share | Q2 2021: $6.11 (loss) per share | Q3 2021: $0.86 (loss) per share | Q1 2022: $0.03 per share | Q2 2022: $0.55 per share | Q3 2022: $0.31 (loss) per share | Q1 2023: $1.04 per share | Q2 2023: $1.52 per share | Q3 2023: $2.14 per share | Q1 2024: $0.23 (loss) per share | Q2 2024: $2.49 per share | Q3 2024: $3.42 per share | Q1 2025: $1.52 (loss) per share | Q2 2025: $11.74 (loss) per share | Q3 2025: $4.08 per share.
• Over the full 17 years of available data (2009 to 2025), Jazz Pharmaceuticals plc's Earnings Per Share Diluted has declined by 2,439.1%.
• Historical annual values: Fiscal year 2025: $5.84 (loss) per share | Fiscal year 2024: $8.65 per share | Fiscal year 2023: $6.10 per share | Fiscal year 2022: $3.58 (loss) per share | Fiscal year 2021: $5.52 (loss) per share | Fiscal year 2020: $4.22 per share | Fiscal year 2019: $9.09 per share | Fiscal year 2018: $7.30 per share | Fiscal year 2017: $7.96 per share | Fiscal year 2016: $6.41 per share | Fiscal year 2015: $5.23 per share | Fiscal year 2014: $0.93 per share | Fiscal year 2013: $3.51 per share | Fiscal year 2012: $4.79 per share | Fiscal year 2011: $2.67 per share | Fiscal year 2010: $0.83 per share | Fiscal year 2009: $0.23 (loss) per share.
• Data sourced from SEC EDGAR public filings as of August 8, 2026.

Last verified: August 8, 2026